Our Latest News

Millennium Health Appoints Dave Henderson as Chief Information Officer

Henderson brings more than 20 years of information technology experience

SAN DIEGO, Calif. – November 13, 2017 – Millennium Health, a leading health solutions company, today announced the appointment of Dave Henderson as Chief Information Officer. In his position, Henderson will be responsible for all aspects of information technology strategy and implementation for the Company. He will be reporting directly to Michael Keane, chief financial officer, Millennium Health.Read More

U.S. Department of Veterans Affairs Awards Millennium Health with Federal Supply Schedule Contract for Pharmacogenetic Testing

SAN DIEGO, Calif. October 4, 2017 – In 2013, the U.S. Department of Veterans Affairs (VA) Office of Acquisition and Logistics National Acquisition Center awarded Millennium Health, a leading health solutions company, a Federal Supply Schedule (FSS) contract V797D-30178 under schedule 621II Medical Laboratory Testing and Analysis contract. Recently, VA modified Millennium’s FSS contract to add its pharmacogenetic test, Millennium PGTSM. Clinicians may now use the test to help individualize prescription medication decisions for veterans, in the areas of mental health and pain management. The Veterans Health Administration operates the nation’s largest integrated health care system with more than 1,700 health-care facilities across the country and serves nine million enrolled veterans each year.
Read More

Millennium Health Receives MAGNET GROUP Contract for Pharmacogenetic Testing and Medication Monitoring

SAN DIEGO Sept. 25, 2017 – The Mid-Atlantic Group Network of Shared Services (MAGNET GROUP), recently awarded Millennium Health, a leading health solutions company, with a contract for its pharmacogenetic test, Millennium PGTSM, and its medication monitoring services, Millennium UDTSM and Millennium OFTSM. The 9,500 health care providers within the MAGNET GROUP network now have access to these tests to help personalize treatment decisions for patients.

Read More

New Study Finds Heroin-Positive Patients Have Increasing Co-Occurrence of Non-Prescribed Fentanyl

The study demonstrates evidence of an escalating national epidemic

SAN DIEGO Sept. 20, 2017 – A new study examined urine drug test (UDT) results to measure the co-occurrence of non-prescribed fentanyl in populations of heroin-positive healthcare patients across the United States. The study revealed a 3,000 percent increase of non-prescribed fentanyl in heroin-positive patients between January 2013 and January 2017. Regionally, 5 of the 9 U.S. Census regions exhibited a dramatic increase in the co-occurrence of fentanyl use in the heroin-positive population, with New England exhibiting the greatest jump climbing from 3 percent to 76 percent.Read More

Millennium Health Announces Eugene I. Davis as Chairman of the Board and Jennifer Strickland as Chief Executive Officer

Planned transition of Ronald A. Rittenmeyer takes effect immediately

SAN DIEGO August 31, 2017 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Eugene I. Davis as Chairman of the Board and Jennifer Strickland, PharmD, BCPS, as Chief Executive Officer and Board Member. As part of a planned transition, Ronald A. Rittenmeyer steps down as Chairman and CEO and will serve in an advisory role through the end of the year.

Read More

New Study Finds One-Third of Patients Experience Uncontrolled Postoperative Pain

The study will be presented at the 12th Annual Perioperative Medicine Summit in Fort Lauderdale, FL, March 8-11

SAN DIEGO March 8, 2017 – An abstract and poster publication of a study from Millennium Health, a leading health solutions company, measured the incidence of uncontrolled postoperative pain in the inpatient setting. The study found that approximately 33 percent of patients were treated with injectable opioids for uncontrolled postoperative pain, varying within a range of 26 to 76 percent based on type of surgery.

Read More

Millennium Health Adds Levorphanol to its Medication Monitoring Menu

SAN DIEGO Dec. 12, 2016 – Millennium Health, a leading health solutions company, announced today the availability of a new definitive urine drug test for detecting the opioid medication levorphanol using LC-MS/MS technology. The addition is in response to requests from clinicians who prescribe levorphanol and want to include urine drug monitoring as part of a comprehensive treatment plan.Read More

New Study Supports Definitive Drug Testing To Enhance Substance Use Disorders Treatment

SAN DIEGO Nov. 17, 2016 – Millennium Health, a leading health solutions company, and Brightpoint Health, a nonprofit medical and mental health care provider, announced the publication of a new study that suggests medically necessary medication monitoring definitive drug testing using Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS), can help clinicians enhance treatment outcomes in Substance Use Disorders (SUDs). The study was published in the “Journal of Addiction Medicine.”Read More